ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $560,745 | -31.0% | 102,889 | -15.1% | 0.39% | -53.4% |
| Q2 2023 | $813,024 | -21.0% | 121,166 | +4.0% | 0.83% | +20.2% |
| Q1 2023 | $1,029,225 | -36.1% | 116,560 | -44.7% | 0.69% | -48.9% |
| Q4 2022 | $1,610,550 | -26.0% | 210,805 | -31.1% | 1.36% | +8.2% |
| Q3 2022 | $2,177,000 | -18.5% | 305,805 | -7.3% | 1.25% | -49.0% |
| Q2 2022 | $2,670,000 | -35.2% | 329,981 | +11.1% | 2.45% | -26.8% |
| Q1 2022 | $4,123,000 | +113.2% | 297,048 | +330.9% | 3.35% | +182.6% |
| Q4 2021 | $1,934,000 | – | 68,940 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |